AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2010

Dec 15, 2010

33081_dirs_2010-12-15_bedd8c54-3f7a-4eac-bc48-719b7e7610d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VENTRUS BIOSCIENCES INC (VTUS)
CIK: 0001426800
Period of Report: 2010-12-15

Reporting Person: Rowland Thomas Andrew (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18387	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$	2020-11-10	Common Stock (35000)		Direct

Footnotes

F1: The options vested 1/3 on 3/1/2009 and the remaining 2/3 will vest in equal installments on the first, second and third
anniversaries after 3/1/2009.

F2: The price is equal to the lowest price paid in the issuer's next qualified equity financing (as defined in the issuer's
existing 2010 Convertible Promissory Notes).